Federated Hermes’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $198M | Buy |
1,785,716
+499,413
| +39% | +$45.2M | 0.29% | 83 |
|
|
2026
Q1 | $112M | Sell |
1,286,303
-337,538
| -21% | -$32.8M | 0.18% | 125 |
|
|
2025
Q4 | $174M | Sell |
1,623,841
-104,044
| -6% | -$11M | 0.29% | 90 |
|
|
2025
Q3 | $174M | Buy |
1,727,885
+41,391
| +2% | +$3.84M | 0.31% | 80 |
|
|
2025
Q2 | $107M | Buy |
1,686,494
+94,623
| +6% | +$5.79M | 0.2% | 139 |
|
|
2025
Q1 | $84.3M | Buy |
1,591,871
+42,236
| +3% | +$2.34M | 0.18% | 140 |
|
|
2024
Q4 | $86.7M | Sell |
1,549,635
-114,265
| -7% | -$6.31M | 0.19% | 137 |
|
|
2024
Q3 | $87.2M | Buy |
1,663,900
+3,116
| +0.2% | +$149K | 0.19% | 142 |
|
|
2024
Q2 | $68.2M | Sell |
1,660,784
-313
| -0% | -$12.5K | 0.16% | 171 |
|
|
2024
Q1 | $72M | Sell |
1,661,097
-649,858
| -28% | -$28.4M | 0.17% | 165 |
|
|
2023
Q4 | $106M | Sell |
2,310,955
-30,380
| -1% | -$958K | 0.26% | 89 |
|
|
2023
Q3 | $53.7M | Sell |
2,341,335
-1,550,348
| -40% | -$34.7M | 0.14% | 184 |
|
|
2023
Q2 | $64.2M | Hold |
3,891,683
| – | – | 0.16% | 154 |
|
|
2023
Q1 | $69.4M | Sell |
3,891,683
-2,412,799
| -38% | -$60.6M | 0.17% | 133 |
|
|
2022
Q4 | $184M | Sell |
6,304,482
-2,384
| -0% | -$61.3K | 0.51% | 38 |
|
|
2022
Q3 | $155M | Buy |
6,306,866
+1,911,266
| +43% | +$35.5M | 0.45% | 45 |
|
|
2022
Q2 | $18.2M | Sell |
4,395,600
-669,513
| -13% | -$3.66M | 0.05% | 410 |
|
|
2022
Q1 | $58.4M | Buy |
5,065,113
+2,261,778
| +81% | +$19.9M | 0.13% | 200 |
|
|
2021
Q4 | $28M | Sell |
2,803,335
-207,718
| -7% | -$2.33M | 0.05% | 408 |
|
|
2021
Q3 | $39.3M | Sell |
3,011,053
-4,158
| -0.1% | -$63.5K | 0.07% | 332 |
|
|
2021
Q2 | $59M | Sell |
3,015,211
-95,642
| -3% | -$1.99M | 0.11% | 242 |
|
|
2021
Q1 | $66.2M | Buy |
3,110,853
+493,253
| +19% | +$14.3M | 0.13% | 207 |
|
|
2020
Q4 | $77.8M | Buy |
2,617,600
+350,000
| +15% | +$8.9M | 0.16% | 165 |
|
|
2020
Q3 | $49.1M | Buy |
2,267,600
+1,529
| +0.1% | +$35.1K | 0.12% | 208 |
|
|
2020
Q2 | $50.5M | Buy |
2,266,071
+171
| +0% | +$3.33K | 0.13% | 187 |
|
|
2020
Q1 | $34.5M | Buy |
2,265,900
+107,881
| +5% | +$1.93M | 0.1% | 218 |
|
|
2019
Q4 | $49.5M | Buy |
2,158,019
+692,619
| +47% | +$15.4M | 0.11% | 218 |
|
|
2019
Q3 | $31.6M | Buy |
1,465,400
+573,200
| +64% | +$12.3M | 0.08% | 262 |
|
|
2019
Q2 | $19.6M | Hold |
892,200
| – | – | 0.05% | 358 |
|
|
2019
Q1 | $24.5M | Sell |
892,200
-1,044
| -0.1% | -$30K | 0.06% | 302 |
|
|
2018
Q4 | $24M | Buy |
893,244
+102,823
| +13% | +$2.84M | 0.07% | 296 |
|
|
2018
Q3 | $23.1M | Buy |
790,421
+540,421
| +216% | +$17.1M | 0.05% | 321 |
|
|
2018
Q2 | $7.82M | Buy |
250,000
+100,000
| +67% | +$2.73M | 0.02% | 551 |
|
|
2018
Q1 | $2.98M | Hold |
150,000
| – | – | 0.01% | 800 |
|
|
2017
Q4 | $4.36M | Buy |
+150,000
| New | +$3.97M | 0.01% | 656 |
|
Other funds holding RYTM
RCM
BBA
PA
Federated Hermes's RYTM Position: Q2 2026 in Review
Federated Hermes increased its Rhythm Pharmaceuticals (RYTM) stake by 39% in Q2 2026, buying an estimated $45.2M and bringing the position to 1,785,716 shares worth $198M. The position accounts for 0.29% of the portfolio, ranked #83.
Federated Hermes first reported a position in RYTM in Q4 2017 and has held it in 35 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- Federated Hermes held 1,785,716 shares of Rhythm Pharmaceuticals worth $198M as of Q2 2026.
- Federated Hermes bought 499,413 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $45.2M.
- Rhythm Pharmaceuticals made up 0.29% of Federated Hermes's portfolio in Q2 2026, its #83 holding.
- Federated Hermes first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.